Aerska is a biotechnology company developing RNA interference (RNAi) medicines to treat, delay, and prevent diseases of the brain and central nervous system. The company pairs next-generation RNAi therapeutics with receptor-mediated "brain shuttle" delivery technology engineered to cross the blood-brain barrier and silence disease-causing genes in… - View it on GitHub